Skip Nav Destination
Close Modal
Update search
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Date
Availability
Search All AAP Sites
Can't find what you're looking for? Search for content across all of AAP's sites.
1-20 of 301
Pharmacology
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
News
Published: July 01, 2025
TOPICS:
Obesity,
Pharmacology
Abstract
Metabolic dysfunction-associated steatotic liver disease, formerly known as nonalcoholic fatty liver disease, is the hepatic manifestation of obesity. Left untreated, it can progress to steatohepatitis, fibrosis and cirrhosis.
News
Published: June 17, 2025
Abstract
Sarepta Therapeutics Inc. has paused shipments of Elevidys for non-ambulatory patients and a clinical study after a second patient died of acute liver failure.
News
Published: June 01, 2025
TOPICS:
Pharmacology,
Therapeutics
Abstract
Dozens of orphan drugs were approved for pediatric patients with rare diseases.
News
Published: May 12, 2025
Abstract
Patient characteristics like severity of ADHD explain the links between stimulants and psychotic experiences.
News
Drug shortages hit children harder than adults; solutions sought
Available to PurchasePublished: April 30, 2025
TOPICS:
Pharmacology
Abstract
Addressing shortages on a national scale requires policy changes and efforts to ensure fair distribution of drugs during times of shortage as well as enhancing research on pediatric drugs so more therapeutic options are available.
News
Published: April 26, 2025
TOPICS:
Asthma,
Pharmacology
Abstract
The increase in Flovent users stopping inhaled steroids was greatest for children under 6 years and for children insured with Medicaid.
News
FDA seeks pediatrician input on therapeutic development for children
Available to PurchasePublished: April 01, 2025
Abstract
Input from interested parties will be incorporated into the FDA’s report to Congress on the implementation and impact of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act.
News
Pediatricians play key role in preventing, mitigating overdoses
Available to PurchasePublished: April 01, 2025
TOPICS:
Pharmacology,
Substance Use
Abstract
While opioids represent a significant concern, other potentially hazardous agents such as beta-blockers, psychotropics and common household medications like acetaminophen and iron supplements also warrant attention.
News
Published: March 21, 2025
TOPICS:
Allergy/Immunology,
Pharmacology
Abstract
The Food and Drug Administration (FDA) has approved neffy epinephrine nasal spray for emergency treatment of type I allergic reactions in children as young as 4 years who weigh at least 33 pounds.
News
Myriad treatments approved for allergic diseases in pediatric patients
Available to PurchasePublished: January 01, 2025
Abstract
One in four U.S. children suffers from allergic diseases, and more than 6% of children are diagnosed with asthma, according to the Centers for Disease Control and Prevention.
News
Gene therapies for sickle cell disease show promise but access barriers remain
Available to PurchasePublished: December 01, 2024
TOPICS:
Hematology/Oncology,
Pharmacology
Abstract
The Food and Drug Administration approved two gene therapy strategies for patients 12 years and older with severe sickle cell disease. While these therapies have had early therapeutic success, patients often face cost and logistical hurdles to accessing them.
News
Published: November 18, 2024
TOPICS:
Infectious Diseases,
Pharmacology
Abstract
Appropriate antibiotic use and vaccination can help drive down rates of these infections, and AAP resources can guide pediatricians.
News
Published: November 18, 2024
TOPICS:
Pharmacology,
Substance Use
Abstract
A new AAP clinical report describes risk and protective factors, motives and sources of nonmedical prescription drug use among adolescents and young adults. It also outlines what pediatricians can do to prevent and reduce harms related to such use.
News
Published: November 07, 2024
Abstract
After extensive review, the Food and Drug Administration is proposing to remove oral phenylephrine from over-the-counter nasal decongestant products. Public comments about the proposed order will be accepted through May 7, 2025.
News
Published: October 31, 2024
TOPICS:
Fetus/Newborn Infant,
Hematology/Oncology,
Infectious Diseases,
Ophthalmology,
Pharmacology,
RSV,
Vaccine/Immunization
Abstract
Supply chain issues, manufacturing difficulties and increased demand have contributed to supply issues with a variety of drugs, immunizations and medical devices.
News
FDA, FTC warn of risks to children from copycat food products containing delta-8 THC
Available to PurchasePublished: October 01, 2024
TOPICS:
Pharmacology,
Substance Use
Abstract
Delta-8 THC is an intoxicating substance found in low amounts in cannabis plants and likely is produced by synthetic methods.
News
Published: September 30, 2024
Abstract
The guideline addresses how to minimize risks and alleviate disparate pain treatment.
News
Published: September 27, 2024
TOPICS:
Hematology/Oncology,
Pharmacology
Abstract
The FDA recommends clinicians stop prescribing the treatment and patients talk to their doctor about starting a different treatment.
News
Published: September 13, 2024
TOPICS:
Pharmacology,
Substance Use
Abstract
Pediatricians wrote just 6% of the dispensed naloxone prescriptions for adolescents despite a 991% increase during the study period.
News
Pediatricians encouraged to join FDA workshops on pediatric drug development
Available to PurchasePublished: September 01, 2024
TOPICS:
Pharmacology,
Public Health,
Therapeutics
Abstract
The Food and Drug Administration organizes public workshops to analyze issues that confound the development and use of pediatric therapeutics and to discuss and advance potential solutions.
1
